Editorial team
ioQuanta Research Desk
-
Evidence date ·Could SIRT1 activation help preserve memory as the brain ages?
Review or Meta-AnalysisA 2026 review surveys mouse studies linking SIRT1 activity to cognition and discusses resveratrol, metformin and exercise. Human memory benefits remain unproven.
-
Evidence date ·What changed after the older mice received the drug?
Peer-Reviewed PaperOlder mice with Alzheimer’s-related mutations slept more during their usual rest period by week five of MW151 treatment. Whether it helps people is unknown.
-
Evidence date ·How lingering stressed cells may connect kidney injury to scarring
Review or Meta-AnalysisPersistent senescent cells may promote kidney scarring. Human data are observational; animal experiments suggest a causal role, but patient benefit is unproven.
-
Evidence date ·How signals around a broken bone change as it heals
Review or Meta-AnalysisA March 2026 review maps signals associated with senescence across fracture repair. Mouse drug results are encouraging, but patient benefit remains unproven.
-
Evidence date ·Could targeting stressed brain cells help people with neurodegenerative disease?
Review or Meta-AnalysisA review describes signs of senescence in different brain cells across Alzheimer’s, Parkinson’s and multiple sclerosis. A five-person pilot found no significant cognitive change.
-
Evidence date ·Could natural killer cells help older adults stay healthy?
Review or Meta-AnalysisA 2026 review connects aging-related changes in natural killer cells with immune surveillance. Tests and preventive treatments still need validation.
-
Evidence date ·How a lifelong virus may affect health during effective HIV treatment
Review or Meta-AnalysisA 2026 review explores how cytomegalovirus may sustain inflammation during treated HIV. Early letermovir results do not show that the drug prevents illness.
-
Evidence date ·How might virus-shaped particles guide a cancer vaccine’s immune signal to lymph nodes?
Review or Meta-AnalysisA review discusses dendritic-cell-mediated targeting and lymphatic drainage as distinct strategies for virus-like particles. Production and immune variability remain hurdles.
-
Evidence date ·Why cancer vaccine exosomes need more than the right cargo
Review or Meta-AnalysisA March 2026 review compares ways to load tumor antigens into exosomes and direct the vesicles toward immune cells. Early human studies show limited, varied responses.
-
Evidence date ·What changed in mouse memory and brain immune cells after resveratrol?
Peer-Reviewed PaperIn an accelerated-aging mouse model, resveratrol improved maze performance and lowered brain inflammatory markers. Cultured cells showed reduced STING pathway signaling.